These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Langerhans cell density in epithelial skin tumors correlates with epithelial differentiation but not with the peritumoral infiltrate. Smolle J; Soyer HP; Ehall R; Bartenstein S; Kerl H J Invest Dermatol; 1986 Oct; 87(4):477-9. PubMed ID: 3489792 [TBL] [Abstract][Full Text] [Related]
24. Number of Langerhans cells is decreased in premalignant keratosis and skin cancers. Shevchuk Z; Filip A; Shevchuk V; Kashuba E Exp Oncol; 2014 Mar; 36(1):34-7. PubMed ID: 24691282 [TBL] [Abstract][Full Text] [Related]
25. True histiocytic neoplasm of Langerhans' cell type. Delabie J; De Wolf-Peeters C; De Vos R; Vandenberghe E; Kennes K; De Jonge I; Desmet V J Pathol; 1991 Mar; 163(3):217-23. PubMed ID: 1707450 [TBL] [Abstract][Full Text] [Related]
27. Langerhans cells and mycosis fungoides--a critical overview of their pathogenic role in the disease. Bani D; Pimpinelli N; Moretti S; Giannotti B Clin Exp Dermatol; 1990 Jan; 15(1):7-12. PubMed ID: 2311286 [TBL] [Abstract][Full Text] [Related]
28. Huriez syndrome: case report with a detailed analysis of skin dendritic cells. Guerriero C; Albanesi C; Girolomoni G; De Simone C; Capizzi R; Amerio P; Tulli A Br J Dermatol; 2000 Nov; 143(5):1091-6. PubMed ID: 11069529 [TBL] [Abstract][Full Text] [Related]
29. Langerhans cell histiocytosis arising from a BCC: a case report and review of the literature. Patel P; Talpur R; Duvic M Cutis; 2010 Jun; 85(6):295-300. PubMed ID: 20666189 [TBL] [Abstract][Full Text] [Related]
30. [Epidermal reticular CD1 pattern]. Niedecken HW; Lutz G; Uerlich M; Bauer R Z Hautkr; 1989 Sep; 64(9):798-800, 803-4. PubMed ID: 2479182 [TBL] [Abstract][Full Text] [Related]
32. Cytology of primary cutaneous Langerhans cell histiocytosis with a malignant phenotype. A case report. Itoh H; Hinoura Y; Aratake Y; Sato S; Ohno A; Miyaguni H; Kataoka H; Koono M Acta Cytol; 2002; 46(4):731-4. PubMed ID: 12146041 [TBL] [Abstract][Full Text] [Related]
33. The utility of PU.1 as an immunohistochemical marker for histiocytic and dendritic lesions of the skin. Muirhead D; Stone MS; Syrbu SI Am J Dermatopathol; 2009 Jul; 31(5):432-5. PubMed ID: 19542915 [TBL] [Abstract][Full Text] [Related]
34. Analysis of non-neoplastic cells in cutaneous B-cell lymphomas. Willemze R; Meijer CJ J Dermatol Surg Oncol; 1984 Apr; 10(4):315-8. PubMed ID: 6608545 [No Abstract] [Full Text] [Related]
35. Alterations in Langerhans cells during growth of transplantable murine tumors. Bergfelt L; Bucana C; Kripke ML J Invest Dermatol; 1988 Aug; 91(2):129-35. PubMed ID: 2969402 [TBL] [Abstract][Full Text] [Related]
36. Nonmelanomatous skin cancer: new concepts in pathogenesis. Richey HK; Fenske NA South Med J; 1987 Mar; 80(3):362-5. PubMed ID: 3824023 [No Abstract] [Full Text] [Related]
37. Heterogeneity of dermal OKT6+ cells in inflammatory and neoplastic skin diseases. Berti E; Cavicchini S; Cusini M; Monti M; Parolini F; Caputo R J Am Acad Dermatol; 1985 Mar; 12(3):507-14. PubMed ID: 3872892 [TBL] [Abstract][Full Text] [Related]
38. Cutaneous Langerhans cell histiocytosis in an elderly woman. Hu JC; Ra S; Gutierrez MA Dermatol Online J; 2010 Oct; 16(10):6. PubMed ID: 21062600 [TBL] [Abstract][Full Text] [Related]